Recent Finacing
Recent Raise
Sideris Pharmaceuticals is a biopharmaceutical company developing SP-420, an orally active small-molecule iron chelator for transfusion-related iron overload, with operations in Boston and Gainesville.
Focus Areas
Recent Investors
Total Raised
Funding round
Investors